Journal
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
Volume 7, Issue 3, Pages 135-146Publisher
WILEY
DOI: 10.1002/psp4.12282
Keywords
-
Categories
Ask authors/readers for more resources
A cross-industry survey was conducted to assess the landscape of preclinical quantitative systems pharmacology (QSP) modeling within pharmaceutical companies. This article presents the survey results, which provide insights on the current state of preclinical QSP modeling in addition to future opportunities. Our results call attention to the need for an aligned definition and consistent terminology around QSP, yet highlight the broad applicability and benefits preclinical QSP modeling is currently delivering.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available